Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends
Company Report I 2024-08-12 I 124 Pages I Quaintel Research
Report Summary
Becton, Dickinson and Company (BDX:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Trends Report is a comprehensive and easily accessible overview of Becton, Dickinson and Company's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Becton, Dickinson and Company including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Becton, Dickinson and Company's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Becton, Dickinson and Company's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Becton, Dickinson and Company's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Becton, Dickinson and Company's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Becton, Dickinson and Company enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It provide customer solutions that are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology care; enhancing the diagnosis of infectious diseases and cancers; and advancing cellular research and applications. BD's operations consist of three worldwide business segments: BD Medical, BD Life Sciences and BD Interventional. The company was incorporated under the laws of the State of New Jersey in November 1906 with headquartered in United States.
Becton, Dickinson and Company in the News:-
- 10-Jul-2024 - BD Statement on Supplier Issue Impacting BD BACTEC Blood Culture Vials
- 10-Jul-2024 - BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
- 03-Jul-2024 - BD to Announce Financial Results for its Third Quarter of Fiscal 2024
- 26-Jun-2024 - New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
- 20-Jun-2024 - BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Becton, Dickinson and Company's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Becton, Dickinson and Company:
- Becton, Dickinson and Company Value Chain Analysis
- Becton, Dickinson and Company Porter's Five Forces Analysis
- Becton, Dickinson and Company VRIO Analysis
- Becton, Dickinson and Company BCG Analysis
- Becton, Dickinson and Company Segmentation, Targeting and Positioning (STP) Analysis
- Becton, Dickinson and Company Ansoff Matrix Analysis
Table of Contents
COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 6
Charts 7
Becton, Dickinson and Company - Key Company Facts 8
Becton, Dickinson and Company - Company Description 9
Becton, Dickinson and Company - Top Executives 10
Becton, Dickinson and Company- Top Executives Biographies 11
Becton, Dickinson and Company- Head Office & Locations 13
Head Office - Country 13
Key Subsidiaries 14
Becton, Dickinson and Company - Products and Services 16
Products 16
Becton, Dickinson and Company - Historic Events 18
Becton, Dickinson and Company - Company's Management Discussion 20
Becton, Dickinson and Company - Corporate Strategy 30
Becton, Dickinson and Company - Business Description 34
BD Medical 35
BD Life Sciences 36
BD Interventional 37
Becton, Dickinson and Company - ESG Spotlight 38
Environment 38
Social 39
Corporate Governance 39
Becton, Dickinson and Company - SWOT Analysis 41
Overview 41
Strengths 43
Weaknesses 46
Opportunities 48
Threats 51
Becton, Dickinson and Company - PESTLE Analysis 54
Overview 54
Political Factors 56
Economic Factors 58
Social Factors 60
Technological Factors 63
Legal Factors 66
Environmental Factors 68
Becton, Dickinson and Company - Financial Deep Dive 69
Share Price Trend - Aug-2023 to Aug-2024 (Average Share Closing Price) 69
Profit and Loss Statement 71
Summary of Profit and Loss Statement 71
Balance Sheet 73
Summary of Balance Sheet 73
Cash Flow Statement 75
Summary of Cash Flow Statement 75
Key Financial Ratio Analysis 77
Becton, Dickinson and Company - Ratio Charts 78
Activity Ratio Charts 78
Growth Ratios Charts 79
Leverage Ratio Charts 80
Liquidity Ratio Charts 81
Profitability Ratio Charts 82
Competing Players 83
Snapshot of Competing Players 84
Baxter International Inc. 84
Key Company Facts 84
Company Description 84
Snapshot of Competing Players 86
Koninklijke Philips N.V. 86
Key Company Facts 86
Company Description 86
Snapshot of Competing Players 88
Medtronic plc 88
Key Company Facts 88
Company Description 88
Snapshot of Competing Players 90
Stryker Corporation 90
Key Company Facts 90
Company Description 90
Snapshot of Competing Players 92
Thermo Fisher Scientific Inc. 92
Key Company Facts 92
Company Description 92
Becton, Dickinson and Company - In the News 94
10-Jul-2024 - BD Statement on Supplier Issue Impacting BD BACTEC Blood Culture Vials 94
10-Jul-2024 - BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 95
03-Jul-2024 - BD to Announce Financial Results for its Third Quarter of Fiscal 2024 96
26-Jun-2024 - New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases 97
20-Jun-2024 - BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts 97
06-May-2024 - BD, City of Hope to Offer Pharmacy Residency Program for Medication-Use Safety and Policy 99
30-Apr-2024 - BD Board Declares Dividend 100
29-Apr-2024 - BD to Present at Bank of America Securities Health Care Conference 2024 100
09-Apr-2024 - BD Named a Best Employer for Excellence in Employee Well-Being 100
27-Mar-2024 - New Survey Reveals Patients Receive Too Many Needlesticks 102
26-Mar-2024 - BD Named Among Fortune's Most Innovative Companies 104
21-Mar-2024 - BD Increases Domestic Production to Support U.S. Health Care Need for Syringes 105
18-Mar-2024 - BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study 106
13-Mar-2024 - New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities 107
11-Mar-2024 - BD Names Rian Seger President of BD Surgery 108
Becton, Dickinson and Company - Key Deals 109
14-Mar-2024 - BD Collaborates with GOCC to Combat Sepsis in Poland 109
21-Feb-2024 - BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore 111
30-Jan-2024 - BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing 113
23-Jan-2024 - BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics 114
20-Nov-2023 - BD, Bio Farma Collaborate to Help Eliminate Tuberculosis in Indonesia by 2030 115
03-Aug-2023 - Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company Expand Partnership for Greater Access to Injectable Contraceptive for Women in Low- and Lower-Middle-Income Countries 116
Appendix 118
Definitions 118
SWOT Analysis 118
PESTLE Analysis 118
Value Chain Analysis 118
ESG Spotlight 118
Financial Deep Dive 118
Financial Ratios - 119
Activity Ratios 119
Growth Ratios 120
Leverage Ratios 121
Liquidity Ratios 122
Market Ratios 123
Profitability Ratios 123
Research Methodology 124
Disclaimer 125
Contact Us 125
Tables
Table 1: Becton, Dickinson and Company - Company Facts
Table 2: Becton, Dickinson and Company - Top Executives
Table 3: Becton, Dickinson and Company - Top Executives Biographies
Table 4: Becton, Dickinson and Company - Subsidiaries
Table 5: Becton, Dickinson and Company - Products
Table 6: Becton, Dickinson and Company - Historic Events
Table 7: Becton, Dickinson and Company - Share Price Trend - Aug-2023 to Aug-2024
Table 8: Becton, Dickinson and Company - Ratio Analysis - 2020-2023
Table 9: Becton, Dickinson and Company - Competing Players
Charts
Figure 1: Becton, Dickinson and Company- SWOT Analysis 42
Figure 2: Becton, Dickinson and Company - PESTLE Analysis 55
Figure 3: Becton, Dickinson and Company - Average Share Price Trend - Aug-2023 to Aug-2024 70
Figure 4: Becton, Dickinson and Company - Profit and Loss Statement - 2020-2023 72
Figure 5: Becton, Dickinson and Company - Balance Sheet - 2020-2023 74
Figure 6: Becton, Dickinson and Company - Cash Flow Statement 2020-2023 76
Figure 7: Becton, Dickinson and Company - Activity Ratio Charts 78
Figure 8: Becton, Dickinson and Company - Growth Ratio Charts (Value %) 79
Figure 9: Becton, Dickinson and Company - Leverage Ratio Charts 80
Figure 10: Becton, Dickinson and Company - Liquidity Ratio Charts 81
Figure 11: Becton, Dickinson and Company - Profitability Ratio Charts (Value %) 82
Figure 12: Competing Players - Baxter International Inc. - Key Financials 85
Figure 13: Competing Players - Koninklijke Philips N.V. - Key Financials 87
Figure 14: Competing Players - Medtronic plc - Key Financials 89
Figure 15: Competing Players - Stryker Corporation - Key Financials 91
Figure 16: Competing Players - Thermo Fisher Scientific Inc. - Key Financials 93
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.